Edge Rewrite
restyle Source code View original
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

Jump to content

Methyl-DOB

From Wikipedia, the free encyclopedia
(Redirected from N-Methyl-DOB)
Methyl-DOB
Clinical data
Other namesN-Methyl-DOB; N-Me-DOB; 4-Bromo-2,5-dimethoxy-N-methylamphetamine; MDOB; M-154
Routes of
administration		Oral[1]
Drug classSerotonin receptor modulator; Psychoactive drug
ATC code
  • None
Pharmacokinetic data
Onset of action1.3 hours[1]
Duration of action"Probably rather long"[1]
Identifiers
  • 1-(4-bromo-2,5-dimethoxyphenyl)-N-methylpropan-2-amine
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC12H18BrNO2
Molar mass288.185 g·mol−1
3D model (JSmol)
  • Brc1cc(OC)c(cc1OC)CC(NC)C
  • InChI=1S/C12H18BrNO2/c1-8(14-2)5-9-6-12(16-4)10(13)7-11(9)15-3/h6-8,14H,5H2,1-4H3 checkY
  • Key:GURVSGCCXMIFMQ-UHFFFAOYSA-N checkY
  (verify)

Methyl-DOB, or N-methyl-DOB, also known as 4-bromo-2,5-dimethoxy-N-methylamphetamine, MDOB, or M-154, is a psychoactive drug of the phenethylamine, amphetamine, and DOx families.[1] It is the N-methyl derivative of the psychedelic drug DOB.[1]

Use and effects

[edit]

In his book PiHKAL (Phenethylamines I Have Known and Loved), Alexander Shulgin lists methyl-DOB's dose as greater than 8 mg orally and its duration as "probably rather long".[1] Its onset was about 1.3 hours.[1] Analogously to the case of other N-methylated phenethylamines, the potency of methyl-DOB is dramatically reduced compared to DOB, which has a listed dose of 1 to 3 mg orally.[1]

At tested doses of 8 to 10 mg orally, the effects of methyl-DOB have been reported to include lightheadedness, spaciness, physical effects or body load, tight and rubby teeth, tenseness, exaggerated reflexes, pupil dilation, and next-day hangover.[1] No clear psychoactive or hallucinogenic effects were described.[1] The drug may also potentiate other psychedelic drugs like even on the next day however, with a "severe response" to a low 5 mg dose of psilocybin 24 hours later occurring in one instance.[1]

Interactions

[edit]

Pharmacology

[edit]

Pharmacodynamics

[edit]

Methyl-DOB shows affinity for the serotonin 5-HT2A and 5-HT2C receptors (Ki = 79–80 nM and 98 nM, respectively).[2][3] Its affinities for serotonin 5-HT2 receptors were 1.4- to 9.7-fold lower than those of DOB depending on the receptor and radioligand.[2][3] Methyl-DOB substituted for (R)-DOB in rodent drug discrimination tests, but was approximately 16-fold less potent in comparison.[3]

Chemistry

[edit]

Synthesis

[edit]

The chemical synthesis of methyl-DOB has been described.[1]

Analogues

[edit]

Analogues of methyl-DOB include N-methyl-DOI, IDNNA (N,N-dimethyl-DOI), N-methyl-2C-B, Beatrice (N-methyl-DOM), N-methyl-DOET, N-methyl-TMA-2, and methyl-TMA (N-methyl-TMA), among others.[1]

History

[edit]

Methyl-DOB was first described in the scientific literature by Richard Glennon and colleagues by 1987.[3] Subsequently, it was described in greater detail by Alexander Shulgin in his book PiHKAL (Phenethylamines I Have Known and Loved) in 1991.[1]

Society and culture

[edit]
[edit]

Methyl-DOB is a controlled substance in Canada under phenethylamine blanket-ban language.[4]

See also

[edit]

References

[edit]
  1. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Shulgin, Alexander; Shulgin, Ann (September 1991). PiHKAL: A Chemical Love Story. Berkeley, California: Transform Press. ISBN 0-9630096-0-5. OCLC 25627628. http://www.erowid.org/library/books_online/pihkal/pihkal127.shtml
  2. 1 2 Glennon RA, Raghupathi R, Bartyzel P, Teitler M, Leonhardt S (February 1992). "Binding of phenylalkylamine derivatives at 5-HT1C and 5-HT2 serotonin receptors: evidence for a lack of selectivity". J Med Chem. 35 (4): 734–740. doi:10.1021/jm00082a014. PMID 1542100.
  3. 1 2 3 4 Glennon RA, Titeler M, Seggel MR, Lyon RA (May 1987). "N-methyl derivatives of the 5-HT2 agonist 1-(4-bromo-2,5-dimethoxyphenyl)-2-aminopropane". J Med Chem. 30 (5): 930–932. doi:10.1021/jm00388a032. PMID 3572981.
  4. ↑ "Controlled Drugs and Substances Act". Department of Justice Canada. Retrieved 19 January 2026.
[edit]
Retrieved from "https://en.wikipedia.org/w/index.php?title=Methyl-DOB&oldid=1340530904"